Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-06-13

Clinical Trial Update: Interaction Between Etravirine or Darunavir/Ritonavir and Artemether / Lumefantrine [Phase 1]

View source ↗

Summary

Phase 1 trial update examining potential drug-drug interactions between HIV antiretrovirals (etravirine or darunavir/ritonavir) and the antimalarial artemether/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coartem (artemether-lumefantrine)
  • Intelence (Etravirine)
  • Norvir (ritonavir)
  • PREZISTA (darunavir)

Snippet

Sponsor: Janssen Pharmaceutica N.V., Belgium | Conditions: HIV | Phase 1 | Status: COMPLETED